+Follow
星之心
No personal profile
24
Follow
6
Followers
0
Topic
0
Badge
Posts
Hot
星之心
2020-07-08
xni
Onconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading
星之心
2019-11-06
$SELLAS Life Sciences Group Inc.(SLS)$
upupup
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3516396034245075","uuid":"3516396034245075","gmtCreate":1553302199240,"gmtModify":1553302199240,"name":"星之心","pinyin":"xzxxingzhixin","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":24,"tweetSize":68,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":949386199,"gmtCreate":1594148689311,"gmtModify":1705044011465,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"htmlText":"xni","listText":"xni","text":"xni","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/949386199","repostId":"2046623376","repostType":2,"repost":{"id":"2046623376","kind":"news","pubTimestamp":1593182465,"share":"https://ttm.financial/m/news/2046623376?lang=en_US&edition=fundamental","pubTime":"2020-06-26 22:41","market":"us","language":"zh","title":"Onconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2046623376","media":"自选股智能写手","summary":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.","content":"<p><html><body><article>At 22:41 on June 26, 2020, Beijing time, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plunged 5.58%. As of press time, the stock was quoted at US $0.540 per share, with a turnover of 2,285,820 shares, a turnover rate of 1.36%, and an amplitude of 6.14%.</p><p>According to the latest financial report data, the stock achieved operating income of 52,000.00 US dollars, net profit of-5.09 million US dollars, earnings per share of-0.03 US dollars, gross profit of--, and P/E of-2.35 times.</p><p>In terms of institutional ratings, among all four institutions participating in the rating, 100% of securities firms gave buying recommendations, and no securities firms gave holding or selling recommendations.</p><p>The Biotechnology sector, in which Onconova Therapeutics Inc stock is in, was down 1.99% overall. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc rose significantly, and Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc Relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with larger amplitudes include Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Laboratory</a>, with amplitudes of 76.36%, 57.41%, and 38.37%, respectively.</p><p>About Onconova Therapeutics Inc: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a library of targeted reagents designed to combat important cellular pathways for cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The lead product candidate, Rigosertib, is a small molecule that blocks signaling by targeting the effective cellular pathway of RAS.</p><p>(The above contents are self-selected shares<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed and is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Onconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2020-06-26 22:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 22:41 on June 26, 2020, Beijing time, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plunged 5.58%. As of press time, the stock was quoted at US $0.540 per share, with a turnover of 2,285,820 shares, a turnover rate of 1.36%, and an amplitude of 6.14%.</p><p>According to the latest financial report data, the stock achieved operating income of 52,000.00 US dollars, net profit of-5.09 million US dollars, earnings per share of-0.03 US dollars, gross profit of--, and P/E of-2.35 times.</p><p>In terms of institutional ratings, among all four institutions participating in the rating, 100% of securities firms gave buying recommendations, and no securities firms gave holding or selling recommendations.</p><p>The Biotechnology sector, in which Onconova Therapeutics Inc stock is in, was down 1.99% overall. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc rose significantly, and Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc Relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with larger amplitudes include Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Laboratory</a>, with amplitudes of 76.36%, 57.41%, and 38.37%, respectively.</p><p>About Onconova Therapeutics Inc: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a library of targeted reagents designed to combat important cellular pathways for cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The lead product candidate, Rigosertib, is a small molecule that blocks signaling by targeting the effective cellular pathway of RAS.</p><p>(The above contents are self-selected shares<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed and is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2046623376","content_text":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、克利夫兰生物实验室，振幅分别为76.36%、57.41%、38.37%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"ONTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":932519805,"gmtCreate":1572976588707,"gmtModify":1705411172556,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","listText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","text":"$SELLAS Life Sciences Group Inc.(SLS)$upupup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/932519805","isVote":1,"tweetType":1,"viewCount":1964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":949386199,"gmtCreate":1594148689311,"gmtModify":1705044011465,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"htmlText":"xni","listText":"xni","text":"xni","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/949386199","repostId":"2046623376","repostType":2,"repost":{"id":"2046623376","kind":"news","pubTimestamp":1593182465,"share":"https://ttm.financial/m/news/2046623376?lang=en_US&edition=fundamental","pubTime":"2020-06-26 22:41","market":"us","language":"zh","title":"Onconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2046623376","media":"自选股智能写手","summary":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.","content":"<p><html><body><article>At 22:41 on June 26, 2020, Beijing time, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plunged 5.58%. As of press time, the stock was quoted at US $0.540 per share, with a turnover of 2,285,820 shares, a turnover rate of 1.36%, and an amplitude of 6.14%.</p><p>According to the latest financial report data, the stock achieved operating income of 52,000.00 US dollars, net profit of-5.09 million US dollars, earnings per share of-0.03 US dollars, gross profit of--, and P/E of-2.35 times.</p><p>In terms of institutional ratings, among all four institutions participating in the rating, 100% of securities firms gave buying recommendations, and no securities firms gave holding or selling recommendations.</p><p>The Biotechnology sector, in which Onconova Therapeutics Inc stock is in, was down 1.99% overall. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc rose significantly, and Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc Relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with larger amplitudes include Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Laboratory</a>, with amplitudes of 76.36%, 57.41%, and 38.37%, respectively.</p><p>About Onconova Therapeutics Inc: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a library of targeted reagents designed to combat important cellular pathways for cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The lead product candidate, Rigosertib, is a small molecule that blocks signaling by targeting the effective cellular pathway of RAS.</p><p>(The above contents are self-selected shares<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed and is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Onconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnconova Therapeutics Inc's intraday change plunged 5.58% to $0.540 in early trading\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2020-06-26 22:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 22:41 on June 26, 2020, Beijing time, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plunged 5.58%. As of press time, the stock was quoted at US $0.540 per share, with a turnover of 2,285,820 shares, a turnover rate of 1.36%, and an amplitude of 6.14%.</p><p>According to the latest financial report data, the stock achieved operating income of 52,000.00 US dollars, net profit of-5.09 million US dollars, earnings per share of-0.03 US dollars, gross profit of--, and P/E of-2.35 times.</p><p>In terms of institutional ratings, among all four institutions participating in the rating, 100% of securities firms gave buying recommendations, and no securities firms gave holding or selling recommendations.</p><p>The Biotechnology sector, in which Onconova Therapeutics Inc stock is in, was down 1.99% overall. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc rose significantly, and Vaxart Inc, Citius Pharmaceuticals Inc, Ibio Inc Relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with larger amplitudes include Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Laboratory</a>, with amplitudes of 76.36%, 57.41%, and 38.37%, respectively.</p><p>About Onconova Therapeutics Inc: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a library of targeted reagents designed to combat important cellular pathways for cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The lead product candidate, Rigosertib, is a small molecule that blocks signaling by targeting the effective cellular pathway of RAS.</p><p>(The above contents are self-selected shares<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed and is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2046623376","content_text":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、克利夫兰生物实验室，振幅分别为76.36%、57.41%、38.37%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"ONTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":932519805,"gmtCreate":1572976588707,"gmtModify":1705411172556,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","listText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","text":"$SELLAS Life Sciences Group Inc.(SLS)$upupup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/932519805","isVote":1,"tweetType":1,"viewCount":1964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
